Company: NKLR
Filing Date: 2025-06-26
Form Type: S-4/A
Source: 0001213900-25-058019
Chunk: 205

Company: Terra Innovatum Global N.V.
Filing Date: 2025-06-26
Form: S-4/A
Chunk 205
---
 and licensing, is a lengthy, complex process and projected timelines could vary materially from the actual time necessary to obtain all the required approvals. In addition to the Unit Economics depicted above, Terra Innovatum also provided to GSR III an illustrative schedule, which was the best estimate of a modest ramp -upof sales of Terra Innovatum’s standard 1 MWe SOLO nuclear reactors over a ten -yearperiod. The illustrative schedule included target deployment estimates beginning in Year 0. In Year1, the number of 1 MWe SOLO nuclear reactors expected to reach deployment is 4. In Year2, the number expected to reach deployment is 10. In Year3, the number expected to reach deployment is 50. In Year4, the number expected to reach deployment is 150. In Year5, the number expected to reach deployment is 1,000. In Year6, the number expected to reach deployment is 4,800. In Year7, the number expected to reach deployment is 10,000. The material assumptions underlying the estimated timeline for deployment are related to the (i) number commercial contracts expected to be signed prior to commercial licensing, (ii) the supply chain design and roll -out, and (iii) the preparation of the sites and specific licensing activities associated with the deployment of SOLO at customers’ sites. The number of reactors which could be sold over the years was assessed based on an assessment of the demand in different sectors in the countries in which the reactor could be sold. These market analysis has allowed to evaluate the conservative number of units which would need to be produced, delivered and commissioned after commercial licensing. The analysis of the supply chain and early engagement with suppliers led to identify long lead time items which would need to be ordered several months before the reactor assembly. These analysis allowed to evaluate what would be the conservative production ramp -upTerra Innovatum and its contracted manufacturers would be able to achieve. The schedule was provided to GSR III in the fourth quarter of 2024 to begin evaluating future orders with suppliers of key components that have long lead -times. 80 The target deliveries included in the illustrative schedule assumed that regulatory permitting approvals have been obtained to permit construction and operation of the facilities. However, the regulatory permitting process, including necessary NRC approvals and licensing, is a lengthy, complex process and projected timelines could vary materially from the actual time necessary to obtain all required approvals. While there is some possibility of an expedited approval process for fast reactor technology, there is